The GLP-1 (or glucagon-like peptide-1) drugs are both produced by pharmaceutical giant Novo Nordisk
For example, it was technically possible for an included individual to initiate treatment and experience a stroke event on the same day, but the sensitivity analysis in which no stroke event was permitted in the 90 days before treatment initiation, including on the index date, partly overcame this limitation
This dual mechanism makes Mounjaro one of the most powerful weight-loss options available
"GLP-1 drugs help people reclaim their health," Osborn noted
BHRT can be administered via injections, pellets, and other routes, and its dosed and adjusted based on your needs and goals
Musculoskeletal comorbidities in cardiovascular disease, diabetes and respiratory disease: the impact on activity limitations